Loading clinical trials...
Loading clinical trials...
A Clinical Study to Evaluate the Safety and Efficacy of ZZSW-01 in the Treatment of Patients With Relapsed/Refractory B-cell Malignancies
Conditions
Interventions
ZZSW-01 injection
Locations
1
China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
Start Date
October 28, 2025
Primary Completion Date
September 15, 2028
Completion Date
September 15, 2028
Last Updated
November 21, 2025
NCT06590961
NCT05780034
NCT04943016
Lead Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions